Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase - Full Text View

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

This study has been completed.

Sponsors and Collaborators:	Hvidovre University Hospital IMK-fonden
Information provided by:	Hvidovre University Hospital
ClinicalTrials.gov Identifier:	NCT00162630

Purpose

To evaluate the analgesic potential of an neural blockade (Fascia iliaca compartment) with local anaesthetics in patients with hip fracture immediately after arrival in the emergency department.

Condition	Intervention	Phase
Hip Fracture	Procedure: Fascia Iliaca Compartment Blockade	Phase IV

MedlinePlus related topics:

Fractures Hip Injuries and Disorders Hip Replacement

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study

Official Title:	Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

Further study details as provided by Hvidovre University Hospital:

Primary Outcome Measures:

Pain relief within 3 hours

Secondary Outcome Measures:

Nausea
Pain on transfer
Discomfort with block placement

Estimated Enrollment:	48
Study Start Date:	May 2003
Estimated Study Completion Date:	March 2006

Detailed Description:

Hip fracture patients have severe pain in the acute phase. Traditional analgesic treatment have consisted of intramuscular morphine with its associated side effects. The trial evaluates the Fascia iliaca compartment compared to regular opioid pain therapy in hip fracture patinets immediately after arrival at the emergency department.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Primary hip fracture suspected
able to give informed consent
no substance abuse
no regular opioid therapy
no opioid treatment within the last 6 hours
morphine intolerance
allergies to local anaesthetics

Exclusion Criteria:

Fracture ruled out on x-ray

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00162630

Locations


Denmark
	Hvidovre University Hospital
	Hvidovre, Denmark, 2650

Sponsors and Collaborators

Hvidovre University Hospital

IMK-fonden

Investigators


Study Director:	Nicolai B Foss, MD	Hvidovre University Hospital

More Information

Study ID Numbers:	HHSG-rct-04
First Received:	September 8, 2005
Last Updated:	September 13, 2006
ClinicalTrials.gov Identifier:	NCT00162630
Health Authority:	Denmark: National Board of Health

Keywords provided by Hvidovre University Hospital:

Hip fracture, pain, regional anaesthesia, analgesia

Study placed in the following topic categories:

Hip Fractures

Femoral Fractures

Fractures, Bone

Wounds and Injuries

Disorders of Environmental Origin

Leg Injuries

Pain

Additional relevant MeSH terms:

Hip Injuries

ClinicalTrials.gov processed this record on August 28, 2008